Tokyo, Japan

Hisataka Shikama


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hisataka Shikama: Innovator in Diabetes Complications Prevention

Introduction

Hisataka Shikama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the prevention and treatment of diabetes-related complications.

Latest Patents

His most recent patent involves pyrazole derivatives and compositions that serve as Maillard reaction inhibitors. This patent, which is particularly relevant for its application in preventing and curing various complications associated with diabetes and maturity-onset disorders, highlights the importance of amidinoheterocyclic derivatives. These derivatives are not only beneficial for medical applications but also find utility in cosmetics, external endermic medicines, foods, drinks, luxury grocery items, and functional foods. His patent is a testament to the innovative approaches being explored in the pharmaceutical industry.

Career Highlights

Hisataka Shikama is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing research and development in his field. His work has garnered attention for its potential impact on health and wellness, particularly for individuals suffering from diabetes.

Collaborations

He has collaborated with notable colleagues such as Kunihiro Niigata and Tatsuya Maruyama, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hisataka Shikama's contributions to the field of diabetes treatment through his innovative patent work exemplify the critical role of inventors in advancing healthcare solutions. His ongoing efforts continue to inspire future research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…